Navigation Links
Integration of Agilent's MS technology, Proteome Systems' software to help scientists in proteomics research

Agilent Technologies Inc. (NYSE: A) and Proteome Systems, a leading international proteomics company, today announced they have signed a marketing agreement to collaborate on an integrated solution for the analysis of glycoproteins, molecules that are important in the study of many diseases, including cancer, influenza and arthritis. Under the agreement, Proteome Systems will make its GlycomIQ software, a comprehensive platform for the mass spectrometric analysis of protein-associated glycans (polysaccharides), compatible with the Agilent XCT, XCT Plus and XCT Ultra ion trap mass spectrometers.

Proteome Systems developed GlycomIQ to address the emerging field of glycomics, which examines how glycosylation, or the addition of sugars to proteins, affects biological processes and systems. GlycomIQ comprises kits, consumables and informatics software developed specifically for automated glycan analysis.

"Analysis of protein glycosylation is a demanding task that has often been reserved for specialized laboratories," said Nicolle Packer, executive vice president and head of glycoproteomics of Proteome Systems. "The combination of Agilent's robust, sensitive MS technology with our cutting-edge, automated glycomics system creates a powerful integrated solution that will streamline the study of glycoproteins."

The co-marketed product is expected to be available this summer. Agilent and Proteome Systems will also collaborate on the development of applications and seminars as part of the marketing agreement.

"Agilent is proud of this collaboration with Proteome Systems," said Taia Ergueta, general manager of Agilent's Proteomics and LC/MS business. "It illustrates our ongoing commitment to making leading-edge life science research accessible to more scientists and more laboratories. Using Agilent's protein separation and LC/MS products and Proteome Systems' GlycomIQ software, life scientists will be better able to produce, analyze and integrate complex data on the forefront of proteomics research."


'"/>

Source:Agilent


Related biology news :

1. Long-lived deep-sea fishes imperiled by technology, overfishing
2. UWs Rosetta software to unlock secrets of many human proteins
3. GeneNotes - A novel information management software for biologists
4. New insights into the software of life
5. Nerve cell software keeps track of brain change
6. Wisconsin scientists grow critical nerve cells
7. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
8. UAB scientists discover the origin of a mysterious physical force
9. Fox Chase Cancer Center scientists identify immune-system mutation
10. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
11. U-M scientists find genes that control growth of common skin cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... 7, 2017 Report Highlights ... The global synthetic-biology market reached ... by 2021, growing at a compound annual growth rate (CAGR) ... of the global markets for synthetic biology. - Analyses of ... and projections of compound annual growth rates (CAGRs) through 2021. ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
(Date:2/3/2017)... WASHINGTON , Feb. 3, 2017 A ... Identity Strategy Partners, LLP (IdSP) . Designed to ... in the complex identity market, founding partners Mark ... nearly 35 combined years just in identity expertise that ... tank and non-profit leadership. The Crego-Kephart combined expertise has ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... -- Four US Biotech equities have been ... are: Anthera Pharmaceuticals Inc. (NASDAQ: ANTH), Arrowhead Pharmaceuticals Inc. ... and Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ). ... are growing more bullish on the sector as a ... cash held overseas for tax reason by large US ...
(Date:2/27/2017)... ... 27, 2017 , ... The Catalyst Midwest premix manufacturing facility has ... premix services and private label organic services. , The first organic product is Organic ... operating officer of Dynamite Marketing, which owns the facility. , Catalyst already has received ...
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology ... the National Institute of Mental Health (NIMH) for the further advancement of the company’s ... technology and is expected to deliver therapeutic levels of olanzapine for a period ...
(Date:2/24/2017)... -- Symic Bio, a biopharmaceutical company focused on matrix ... announced today the completion of enrollment for the SHIELD ... trial will evaluate the safety and efficacy of SB-030, ... restenosis following angioplasty. "We,re pleased to ... Nathan Bachtell , M.D., Chief Medical Officer of ...
Breaking Biology Technology: